Cargando…
The Endocannabinoid System as a Therapeutic Target in Diabetic Peripheral Neuropathic Pain: A Review
Diabetic peripheral neuropathy (DPN) is characterized by progressive loss of peripheral nerves, which causes numbness, weakness, and severe pain. The medications available currently provide only modest relief from the pain of DPN and are associated with various side effects, which has generated an e...
Autor principal: | Bagher, Amina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272697/ https://www.ncbi.nlm.nih.gov/pubmed/35832317 http://dx.doi.org/10.4103/jmau.jmau_97_20 |
Ejemplares similares
-
Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain
por: Hossain, Mohammad Zakir, et al.
Publicado: (2020) -
Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review
por: Aly, Esraa, et al.
Publicado: (2021) -
Targeting the Endocannabinoid System for Prevention or Treatment of Chemotherapy-Induced Neuropathic Pain: Studies in Animal Models
por: Masocha, Willias
Publicado: (2018) -
Review of duloxetine in the management of diabetic peripheral neuropathic pain
por: Smith, Timothy, et al.
Publicado: (2007) -
Endocannabinoid System as Therapeutic Target of PTSD: A Systematic Review
por: Steardo, Luca, et al.
Publicado: (2021)